Dexrazoxane | Iron chelator/Ferroptosis inhibitor

CAS:
 24584-09-6
Catalog Number:
 10-2606

Available Options

Size:PriceQuantity 
10 mg$48.00
50 mg$135.00

Dexrazoxane (24584-09-6) is an iron chelator that has been used as a cardioprotective agent employed during chemotherapy with anthraquinone drugs such as daunorubicin or doxorubicin.1 More recently it has been shown to inhibit ferroptosis. It inhibited ferroptosis in a cyclophophosphamide-induced cystitis model2 as well as in doxorubicin-induced cardiomyopathy3,4.

References/Citations:

  1. Jones et al. (2008), Utility of dexrazoxane for the reduction of anthracycline-induced cardiotoxicity; Expert Rev. Cardiovasc. Ther., 6 1311
  2. Mao et al. (2023), Ferroptosis contributes to cyclophosphamide-induced hemorrhagic cystitis;  Chem. Biol. Interact., 384 110701
  3. Zhang et al. (2021), Protective Effects of Dexrazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1; Front. Cardiovasc. Med., 8 685434
  4. Huang et al. (2024), Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy; Redox Biol., 70 103024
CAS:
24584-09-6
Catalog Number:
10-2606
Activity:
Iron chelator/Ferroptosis inhibitor
Chemical Names:
4,4’-[(1S)-1-Methyl-1,2-ethanediyl]bis-2,6-piperazinedione
Alternate Name:
ICRF-187; NSC169780
Molecular Weight:
268.27
Molecular Formula:

C11H16N4O

Solubility:
Soluble in DMSO (60 mg/mL)
Physical Properties:
Off-white solid
Purity:

>98% TLC
NMR: (Conforms)

Storage Temperature:
RT
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored @ -20°C for up to 3 months.
Shipping Code:
RT

Safety Data Sheet:

N/A

Product Data Sheet:

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee